APPLICATION
ANDA213898
TYPE
ANDA
ORIGINAL APPROVAL
2020-07-14
LATEST ACTION
2025-09-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
AMPHETAMINE SULFATEDiscontinued
AMPHETAMINE SULFATE 5MG · TABLET · ORAL
AMPHETAMINE SULFATEDiscontinued
AMPHETAMINE SULFATE 10MG · TABLET · ORAL
Approval history
2025-09-26Labeling · Supplement 3 · standardAP
2024-03-05Labeling · Supplement 2 · standardAP
2022-02-25Labeling · Supplement 1 · standardAP
2020-07-14UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.